Neuroendocrine Tumour
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NCT01578239) | Advanced Accelerator Applications | 2012-09-06 |
Track Neuroendocrine Tumour automatically
Every clearance here is in the API, with alerts when new ones post.